FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica
Ryan Allway September 13th, 2018 News, Top News TORONTO, Sept. 13, 2018 /PRNewswire/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to... Read more
Koios Reaches Distribution Agreement with Western Functional Beverages for Sales in Wyoming
Ryan Allway September 13th, 2018 News, Top News VANCOUVER, Sept. 13, 2018 /CNW/ – Koios Beverage Corp. (CSE:KBEV)(OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce it has entered into a distribution agreement with Western Functional Beverages, a leading distributor of healthy, functional drinks targeting the fitness crowd in... Read more
Namaste Technologies Inc.(NXTTF) signs binding terms sheet to acquire UK-based licensed pharmaceutical distribution company
Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V) (M5BQ.F) (NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Namaste Bahamas Inc. (“Namaste Bahamas”), has signed a Binding Terms Sheet (“Terms Sheet”) to acquire all of the issued and outstanding shares of UK-Based AF Trading Ltd. (operating as “Access... Read more
GT Biopharma Inc. (GTBP) Announces Postive Results For Two Next Generation Trikes In Solid Tumors
GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP) announced today the positive results for two next generation Trispecific Killer Engagers (TriKEs) in solid tumors. These efforts were headed by Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics and Dr. Martin Felices, Co-Director of the Translational Therapy Laboratory at... Read more
CannAwake Corporation (CANX) and American Green Complete Purchase of Nipton Solar Facility
American Green, Inc. (ERBB:OTC) and CannAwake Corporation (CANX:OTCQB) are pleased to announce that they have completed the purchase of the solar power generating station in Nipton, California. Scott Stoegbauer, CannAwake’s president, stated, “After months of very productive negotiations, I am proud to announce that we have finally closed on the purchase... Read more
Marijuana Stocks Continue to Boom as Summer Comes to an End
The summer of this year has been hailed as one of the most important summers for the cannabis industry since its began. With new investments in the cannabis space and the addition of alcohol distributors and producers getting involved in the weed industry, it seems as though now is... Read more
Marijuana Stocks Newsletter – Must Read News For Thursday September 13, 2018
MJStocks Thursday Morning Update For September 13, 2018 Integrated Cannabis Company, Inc. (ICNAF) Develops THC-Infused Spray ProductIntegrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (the “Company” or “Integrated Cannabis”), is pleased to announce the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing... Read more
These Marijuana Companies Are Still Under the Radar
The cannabis market has been quite lucrative for some time now, but new additions to legal measures around the world and the changing public perception of cannabis have all contributed to a fast-paced market growth. As new companies continue to innovate, it seems as though cannabis is the market... Read more
Integrated Cannabis Company, Inc. (ICNAF) Develops THC-Infused Spray Product
Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (the “Company” or “Integrated Cannabis”), is pleased to announce the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in Colorado. Over the past ten months the Company has engaged and worked... Read more
InMed Pharmaceuticals Inc. (IMLFF) Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today reported financial results for the three and twelve months ended June 30, 2018, which is... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )